Finance

Lists
Why is PEHA down 2.74%?
Dive Deeper
PEHA:IDX
Phapros Tbk PT
IDR 284.00
-2.74%
(-8.00) 1D
Sep 29, 4:10:48 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for PEHA...
Open
IDR 292
High
IDR 292
Low
IDR 280
Mkt. cap
238.56B
Avg. vol.
1.91M
Volume
331.20K
Dividend
1.76%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 23, 2026
P/E ratio
5.83
52-wk high
IDR 460
52-wk low
IDR 206
EPS
IDR 49
Shares outstanding
840.00M
No. of employees
1K
Open
IDR 292
High
IDR 292
Low
IDR 280
Mkt. cap
238.56B
Avg. vol.
1.91M
Volume
331.20K
Dividend
1.76%
Quarterly dividend
IDR 1
Ex-dividend date
Jun 23, 2026
P/E ratio
5.83
52-wk high
IDR 460
52-wk low
IDR 206
EPS
IDR 49
Shares outstanding
840.00M
No. of employees
1K
About Phapros Tbk PT
CEO-
Employees1.26K
FoundedJun 21, 1954
Headquarters-
SectorPharmaceutical industry
Websitephapros.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
225.35B
257.30B
221.09B
261.76B
Cost of goods sold
112.30B
107.25B
120.10B
119.25B
Cost of revenue
112.30B
107.25B
120.10B
119.25B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114.54B
75.78B
88.33B
111.85B
Operating expense
103.68B
81.99B
87.81B
112.12B
Total operating expenses
215.97B
189.24B
207.91B
231.38B
Operating income
9.38B
68.06B
13.17B
30.38B
Other non operating income
9.92B
-2.13B
-944.93M
2.20B
EBT including unusual items
3.92B
31.30B
2.03B
19.91B
EBT excluding unusual items
6.86B
57.24B
2.03B
19.91B
Income tax expense
-1.31B
11.54B
1.27B
5.70B
Effective tax rate
-33.46%
36.86%
62.54%
28.63%
Other operating expenses
-4.20B
-9.47B
-520.19M
270.16M
Net income
5.35B
20.30B
1.53B
13.76B
Net profit margin
2.37%
7.89%
0.69%
5.26%
Earnings per share
-
-
-
-
Interest and investment income
1.52B
1.24B
597.94M
-
Interest expense
-13.95B
-9.90B
-10.76B
-12.70B
Net interest expenses
-12.43B
-8.66B
-10.17B
-12.70B
Depreciation and amortization charges
-6.66B
15.28B
-
-
EBITDA
20.43B
78.31B
22.18B
39.39B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps